[From mollusk to man: YKL-40, a novel mediator of severe asthma].
Pretolani
Marina
M
D054392:Adipokines; D000818:Animals; D018927:Anti-Asthmatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000201:enzymology* / Q000503:physiopathology; D001980:Bronchi / Q000473:pathology; D002686:Chitin / Q000378:metabolism; D000071451:Chitinase-3-Like Protein 1; D016207:Cytokines / Q000502:physiology; D018450:Disease Progression; D004847:Epithelial Cells / Q000473:pathology; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005347:Fibroblasts / Q000473:pathology; D005786:Gene Expression Regulation; D006023:Glycoproteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D006801:Humans; D007448:Invertebrates / Q000201:enzymology; D037102:Lectins; D008264:Macrophages / Q000201:enzymology / Q000378:metabolism; D009504:Neutrophils / Q000201:enzymology / Q000378:metabolism; D011134:Polysaccharides / Q000378:metabolism; D013045:Species Specificity
D054392:Adipokines; D018927:Anti-Asthmatic Agents; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D016207:Cytokines; D016326:Extracellular Matrix Proteins; D006023:Glycoproteins; D037102:Lectins; D011134:Polysaccharides; D002686:Chitin